Is HHC Legal in Rhode Island?

Last reviewed: May 22, 2026

HHC is not authorized for sale as a hemp product in Rhode Island. Hexahydrocannabinol is produced by hydrogenating hemp-derived CBD or delta-9 THC, and the Cannabis Control Commission's industrial hemp rules at 230-RICR-80-10-1 prohibit converting CBD or any other cannabinoid into delta-9 THC, THC derivatives, or any other cannabinoid for sale in the program. The same rule package caps total THC in hemp consumables at 1 mg per serving and 5 mg per package, which excludes typical HHC dosing. Licensed cannabis dispensaries regulated under the Rhode Island Cannabis Act do not stock HHC as a separate product line.

Rhode Island Cannabis and Hemp Overview

The Rhode Island Cannabis Act of 2022, RIGL Chapter 21-28.11, legalized adult-use marijuana sales through licensed dispensaries. Hemp sits in a separate statutory bucket. The Hemp Growth Act at RIGL Chapter 2-26 authorizes industrial hemp, and the program rules live at 230-RICR-80-10-1. The Cannabis Control Commission absorbed both programs in 2025. Cannabis authority moved from the DBR Office of Cannabis Regulation to the CCC on May 1, 2025, and the Hemp Growth Program followed on June 29, 2025 under 2025 Public Law Chapter 278, Article 3, Section 1. The CCC's industrial hemp rules took effect as an emergency rule on July 21, 2025 and were finalized December 8, 2025.

What Rhode Island Law Says About HHC

HHC is a hydrogenated form of THC. Manufacturers start with CBD or delta-9 isolated from hemp and run a hydrogenation reaction with a metal catalyst. Two CCC rules block that pathway. The consumable potency cap limits total THC in hemp products to 1 mg per serving, 5 mg per package, or 0.3 percent on a dry weight basis, with total THC defined to include all THC isomers and derivatives. HHC is a THC derivative under that definition. The synthetic-conversion ban then prohibits licensees from converting cannabinoids into delta-9 THC, any THC derivative, or any other cannabinoid, and from selling those products in the program.

The Cannabis Act channel is also closed. RIGL §21-28.11 governs cannabis cultivated, manufactured, and tested under CCC licensing. Hydrogenated hemp derivatives are not part of that supply chain. The DBR's amended Product Designation List, carried forward by the CCC, has not designated HHC products as retail-ready.

How Enforcement Has Played Out

Regulator focus in 2025 was on the intoxicating hemp shadow market. Rhode Island officials paused new hemp retailer licenses while the CCC studied THC-infused beverages and other hemp-derived intoxicants sold in liquor stores and bars. The Commission delivered a public Hemp Program presentation on April 25, 2025, and the General Assembly passed companion resolutions in 2025 ordering a CCC study with dosage, packaging, labeling, and licensing recommendations due by March 1, 2026. None of the available enforcement guidance has carved out an exception for HHC.

What This Means for Retailers

• Pull HHC SKUs from Rhode Island shelves. The synthetic-conversion ban applies to hexahydrocannabinol regardless of starting material.
• Review certificates of analysis for any hemp product line that lists HHC, HHC-O, or HHC-P. Reformulating around the 1 mg per serving cap does not cure the conversion problem.
• Document chain of custody and lab analytics for surviving hemp products. CCC inspectors have asked for proof of source material and reaction history during the program rollout.
• Monitor the CCC's March 1, 2026 report and any 2026 legislation. Bills introduced in 2025 by Reps. Baginski and Slater target hemp-derived intoxicants and are likely to resurface.

What This Means for Consumers

Compliant HHC products are not available at Rhode Island hemp retailers or licensed dispensaries. Online vendors that ship into the state do so outside the Rhode Island regulatory perimeter. HHC metabolizes into compounds that overlap with delta-9 THC metabolites, so it can produce positive results on standard workplace drug screens that target THC-COOH.

Pending Federal Change

The federal floor is tightening too. H.R. 5371 §781 was signed into law November 12, 2025 as part of the Continuing Appropriations and Extensions Act. It rewrites the federal hemp definition to use a total THC standard, caps finished hemp products at 0.4 mg total THC per container, and explicitly excludes synthetic cannabinoids. The new definition takes effect November 12, 2026. Hexahydrocannabinol depends on chemical synthesis and falls inside the excluded category, so federal Farm Bill protection for HHC ends on that date even if a state otherwise tolerated it.

Frequently Asked Questions

Is HHC legal in Rhode Island in 2026?
No. The CCC hemp rules at 230-RICR-80-10-1 ban synthetic conversion, and HHC is manufactured by hydrogenation.

Who regulates hemp products in Rhode Island today?
The Cannabis Control Commission. The Hemp Growth Program transferred to the CCC on June 29, 2025.

Will HHC trigger a positive drug test?
Likely yes. HHC metabolites overlap with delta-9 THC metabolites on common immunoassay panels.

Can a Rhode Island dispensary sell HHC products?
No. Dispensaries are licensed for cannabis cultivated and manufactured under RIGL §21-28.11, not for hydrogenated hemp derivatives.

Does H.R. 5371 §781 affect HHC after November 12, 2026?
Yes. HHC sits inside the synthetic-cannabinoid exclusion that the federal hemp definition adopts on that date.

This page is provided for informational purposes by ComplyAssistAI LLC and is not legal advice. Hemp and cannabis law in Rhode Island changes frequently. For business compliance questions, consult a Rhode Island-licensed cannabis attorney. Find one in our Cannabis Lawyer Directory.